MAPRIMED SA

Overview

MAPRIMED SA is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering CARIPRAZINE; CARIPRAZINE HYDROCHLORIDE; FINGOLIMOD HYDROCHLORIDE (CODE 50996); FLECAINIDE ACETATE PROCESS I (CODE 50064); FLECAINIDE ACETATE PROCESS III (CODE 50970); LEFLUNOMIDE.

API / Drug Master Files

MAPRIMED SA holds 11 active (24 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CARIPRAZINEActive2025-06-16
• OZANIMOD HYDROCHLORIDEActive2023-09-22
• TERIFLUNOMIDEActive2021-12-22
• NITAZOXANIDEActive2019-12-18
• CARIPRAZINE HYDROCHLORIDEActive2019-03-22
• LEFLUNOMIDEActive2018-09-07
• FINGOLIMOD HYDROCHLORIDE (CODE 50996)Active2014-07-08
• FLECAINIDE ACETATE PROCESS III (CODE 50970)Active2014-05-15
• ZOLEDRONIC ACID MONOHYDRATE (CODE 50787)Active2012-05-18
• RASAGILINE MESYLATE (CODE 50855)Active2011-10-06
• FLECAINIDE ACETATE PROCESS I (CODE 50064)Active1994-01-24
• BENZNIDAZOLE (CODE 50954)Inactive2014-12-15
• ARIPIPRAZOLEInactive2013-02-26
• FLECAINIDE ACETATE PROCESS II (CODE 50856)Inactive2010-10-13
• ENALAPRIL MALEATEInactive2007-03-02

Showing 15 of 24 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MAPRIMED SA in our records. PharmaTek screens the full directory against live FDA enforcement data.